Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): Individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH

Philippe Mathurin, Charles L. Mendenhall, Robert L. Carithers, Marie Jose Ramond, Willis C. Maddrey, Peter Garstide, Bernard Rueff, Sylvie Naveau, Jean Claude Chaput, Thierry Poynard

Research output: Contribution to journalArticle

271 Citations (Scopus)

Abstract

Background/Aims: Controversy surrounding the efficacy of corticosteroids in severe alcoholic hepatitis (AH) persists. The aims of our study were: (a) to analyze individual data of patients with severe AH discriminant function (DF) ≥32 from the last three randomized controlled trials; and (b) to identify the independent prognostic factors associated with short-term survival. Methods: Individual data were collected from the three principal investigators. Survival analysis was performed at 28 days using the Kaplan-Meier method and log-rank test. The independent prognostic values were assessed by the proportional hazards regression model. Results: About 102 placebo and 113 corticosteroid patients with DF ≥ 32 were analyzed. At 28 days, corticosteroid patients had significantly higher survival: 84.6 ± 3.4% vs. 65.1 ± 4.8%, P = 0.001. In univariate analysis, corticosteroid treatment, age, DF, albumin, creatinine and encephalopathy were prognostic factors. In multivariate analysis, age (P = 0.0001), serum creatinine (P < 0.002) and corticosteroid treatment (P = 0.002) were independent prognostic variables. A more dramatic decrease of median serum bilirubin values (μmol/1) was observed at 7 and 14 days in corticosteroid patients (P < 0.05): -76.5 vs. -35 and -105 vs. -45. Conclusions: Corticosteroids improved short-term survival of patients with severe AH. Age and serum creatinine are independent prognostic factors. Corticosteroids are recommended for patients with severe AH.

Original languageEnglish (US)
Pages (from-to)480-487
Number of pages8
JournalJournal of Hepatology
Volume36
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Alcoholic Hepatitis
Adrenal Cortex Hormones
Placebos
Survival
Creatinine
Serum
Brain Diseases
Survival Analysis
Bilirubin
Proportional Hazards Models
Albumins
Multivariate Analysis
Randomized Controlled Trials
Research Personnel

Keywords

  • Alcoholic hepatitis
  • Corticosteroids
  • Short-term survival

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH) : Individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. / Mathurin, Philippe; Mendenhall, Charles L.; Carithers, Robert L.; Ramond, Marie Jose; Maddrey, Willis C.; Garstide, Peter; Rueff, Bernard; Naveau, Sylvie; Chaput, Jean Claude; Poynard, Thierry.

In: Journal of Hepatology, Vol. 36, No. 4, 2002, p. 480-487.

Research output: Contribution to journalArticle

Mathurin, Philippe ; Mendenhall, Charles L. ; Carithers, Robert L. ; Ramond, Marie Jose ; Maddrey, Willis C. ; Garstide, Peter ; Rueff, Bernard ; Naveau, Sylvie ; Chaput, Jean Claude ; Poynard, Thierry. / Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH) : Individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. In: Journal of Hepatology. 2002 ; Vol. 36, No. 4. pp. 480-487.
@article{a01e842dcee8461fa7a13482f7e9ceef,
title = "Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): Individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH",
abstract = "Background/Aims: Controversy surrounding the efficacy of corticosteroids in severe alcoholic hepatitis (AH) persists. The aims of our study were: (a) to analyze individual data of patients with severe AH discriminant function (DF) ≥32 from the last three randomized controlled trials; and (b) to identify the independent prognostic factors associated with short-term survival. Methods: Individual data were collected from the three principal investigators. Survival analysis was performed at 28 days using the Kaplan-Meier method and log-rank test. The independent prognostic values were assessed by the proportional hazards regression model. Results: About 102 placebo and 113 corticosteroid patients with DF ≥ 32 were analyzed. At 28 days, corticosteroid patients had significantly higher survival: 84.6 ± 3.4{\%} vs. 65.1 ± 4.8{\%}, P = 0.001. In univariate analysis, corticosteroid treatment, age, DF, albumin, creatinine and encephalopathy were prognostic factors. In multivariate analysis, age (P = 0.0001), serum creatinine (P < 0.002) and corticosteroid treatment (P = 0.002) were independent prognostic variables. A more dramatic decrease of median serum bilirubin values (μmol/1) was observed at 7 and 14 days in corticosteroid patients (P < 0.05): -76.5 vs. -35 and -105 vs. -45. Conclusions: Corticosteroids improved short-term survival of patients with severe AH. Age and serum creatinine are independent prognostic factors. Corticosteroids are recommended for patients with severe AH.",
keywords = "Alcoholic hepatitis, Corticosteroids, Short-term survival",
author = "Philippe Mathurin and Mendenhall, {Charles L.} and Carithers, {Robert L.} and Ramond, {Marie Jose} and Maddrey, {Willis C.} and Peter Garstide and Bernard Rueff and Sylvie Naveau and Chaput, {Jean Claude} and Thierry Poynard",
year = "2002",
doi = "10.1016/S0168-8278(01)00289-6",
language = "English (US)",
volume = "36",
pages = "480--487",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH)

T2 - Individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH

AU - Mathurin, Philippe

AU - Mendenhall, Charles L.

AU - Carithers, Robert L.

AU - Ramond, Marie Jose

AU - Maddrey, Willis C.

AU - Garstide, Peter

AU - Rueff, Bernard

AU - Naveau, Sylvie

AU - Chaput, Jean Claude

AU - Poynard, Thierry

PY - 2002

Y1 - 2002

N2 - Background/Aims: Controversy surrounding the efficacy of corticosteroids in severe alcoholic hepatitis (AH) persists. The aims of our study were: (a) to analyze individual data of patients with severe AH discriminant function (DF) ≥32 from the last three randomized controlled trials; and (b) to identify the independent prognostic factors associated with short-term survival. Methods: Individual data were collected from the three principal investigators. Survival analysis was performed at 28 days using the Kaplan-Meier method and log-rank test. The independent prognostic values were assessed by the proportional hazards regression model. Results: About 102 placebo and 113 corticosteroid patients with DF ≥ 32 were analyzed. At 28 days, corticosteroid patients had significantly higher survival: 84.6 ± 3.4% vs. 65.1 ± 4.8%, P = 0.001. In univariate analysis, corticosteroid treatment, age, DF, albumin, creatinine and encephalopathy were prognostic factors. In multivariate analysis, age (P = 0.0001), serum creatinine (P < 0.002) and corticosteroid treatment (P = 0.002) were independent prognostic variables. A more dramatic decrease of median serum bilirubin values (μmol/1) was observed at 7 and 14 days in corticosteroid patients (P < 0.05): -76.5 vs. -35 and -105 vs. -45. Conclusions: Corticosteroids improved short-term survival of patients with severe AH. Age and serum creatinine are independent prognostic factors. Corticosteroids are recommended for patients with severe AH.

AB - Background/Aims: Controversy surrounding the efficacy of corticosteroids in severe alcoholic hepatitis (AH) persists. The aims of our study were: (a) to analyze individual data of patients with severe AH discriminant function (DF) ≥32 from the last three randomized controlled trials; and (b) to identify the independent prognostic factors associated with short-term survival. Methods: Individual data were collected from the three principal investigators. Survival analysis was performed at 28 days using the Kaplan-Meier method and log-rank test. The independent prognostic values were assessed by the proportional hazards regression model. Results: About 102 placebo and 113 corticosteroid patients with DF ≥ 32 were analyzed. At 28 days, corticosteroid patients had significantly higher survival: 84.6 ± 3.4% vs. 65.1 ± 4.8%, P = 0.001. In univariate analysis, corticosteroid treatment, age, DF, albumin, creatinine and encephalopathy were prognostic factors. In multivariate analysis, age (P = 0.0001), serum creatinine (P < 0.002) and corticosteroid treatment (P = 0.002) were independent prognostic variables. A more dramatic decrease of median serum bilirubin values (μmol/1) was observed at 7 and 14 days in corticosteroid patients (P < 0.05): -76.5 vs. -35 and -105 vs. -45. Conclusions: Corticosteroids improved short-term survival of patients with severe AH. Age and serum creatinine are independent prognostic factors. Corticosteroids are recommended for patients with severe AH.

KW - Alcoholic hepatitis

KW - Corticosteroids

KW - Short-term survival

UR - http://www.scopus.com/inward/record.url?scp=0036105350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036105350&partnerID=8YFLogxK

U2 - 10.1016/S0168-8278(01)00289-6

DO - 10.1016/S0168-8278(01)00289-6

M3 - Article

C2 - 11943418

AN - SCOPUS:0036105350

VL - 36

SP - 480

EP - 487

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 4

ER -